Zida announced it raised $500,000 in an initial filing from an offering of $1.5 Million

Company

Location

About

Zida is an Israeli start-up that is working to revolutionize the treatment of overactive bladder, an issue that hundreds of millions of people suffer from worldwide. We just received 510k clearance for our Zida Control Sock Neuromodulation system. The Zida device was shown to be 80% effective at reducing symptoms of Urinary Frequency, Urgency and Incontinence in a recent clinical study. The story of why we developed the Zida device and the remarkableness of my team has brought us quickly and efficiently to this point. Throughout the development process, we have been in touch with hundreds of patients, physicians, and industry players. Our original intent was to develop and sell a medical device, but the glaring faults in the OAB care pathway drove us to innovate further. The resulting combination of our Zidafy: Digital Health SaaS platform and the Zida Control Sock will exponentially improve patient outcomes.